Objective: To quantify and characterize biopharmaceutical agents and new indications in late-stage development in the United States as of May 2006.
Study Design: Review of drug development databases and other secondary sources.
Methods: Biopharmaceutical was defined as "any biology-based therapeutic that structurally mimics compounds found within the body.
© LitMetric 2025. All rights reserved.